The invention is concerned with novel anthranilic acid derivatives of formula (I)
wherein R1 to R14, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds are HM74A agonists and can be used as medicaments.
本发明涉及式(I)的新型
蒽酸衍
生物,其中R1至R14,m和n如描述和权利要求所定义,以及其生理上可接受的盐和酯。这些化合物是HM74A激动剂,可用作药物。